Telix Pharma to acquire ITM Isotope for $1.65 bln
Australia's Telix Pharmaceuticals has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis.
Sept 21 (Reuters) — The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday: * US spirits maker Sazerac launched a takeover offer for all shares of beverage firm Berentzen for €5.55 ($6.37) apiece, which is supported by Berentzen's supervisory and executive boards.... * Australia's Telix Pharmaceuticals said it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis, further boosting its radiopharmaceutical ambitions....
* State-owned China Rare Earth Group is in talks to acquire Shenghe Resources, said two sources with knowledge of the matter, a move that would consolidate Beijing's control over the sector and give the firm a stake in one of Washington's rare earth plays.... (Compiled by Rajarshi Roy and Miraanta Lowrance in Bengaluru) ((Rajarshi.Roy@thomsonreuters.com)